annual CFO:
-$452.63M-$155.84M(-52.51%)Summary
- As of today (June 28, 2025), PCVX annual cash flow from operations is -$452.63 million, with the most recent change of -$155.84 million (-52.51%) on December 31, 2024.
- During the last 3 years, PCVX annual CFO has fallen by -$331.23 million (-272.86%).
- PCVX annual CFO is now -1385.68% below its all-time high of -$30.47 million, reached on December 31, 2018.
Performance
PCVX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$166.27M-$54.87M(-49.26%)Summary
- As of today (June 28, 2025), PCVX quarterly cash flow from operations is -$166.27 million, with the most recent change of -$54.87 million (-49.26%) on March 31, 2025.
- Over the past year, PCVX quarterly CFO has dropped by -$7.15 million (-4.49%).
- PCVX quarterly CFO is now -1712.84% below its all-time high of -$9.17 million, reached on June 30, 2020.
Performance
PCVX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$459.78M-$7.15M(-1.58%)Summary
- As of today (June 28, 2025), PCVX TTM cash flow from operations is -$459.78 million, with the most recent change of -$7.15 million (-1.58%) on March 31, 2025.
- Over the past year, PCVX TTM CFO has dropped by -$51.55 million (-12.63%).
- PCVX TTM CFO is now -4606.97% below its all-time high of -$9.77 million, reached on March 31, 2019.
Performance
PCVX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PCVX Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -52.5% | -4.5% | -12.6% |
3 y3 years | -272.9% | -500.2% | -238.3% |
5 y5 years | -860.1% | -1119.6% | -801.4% |
PCVX Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -272.9% | at low | -500.2% | at low | -238.3% | +2.2% |
5 y | 5-year | -870.7% | at low | -1712.8% | at low | -895.2% | +2.2% |
alltime | all time | -1385.7% | at low | -1712.8% | at low | -4607.0% | +2.2% |
PCVX Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$166.27M(+49.3%) | -$459.78M(+1.6%) |
Dec 2024 | -$452.63M(+52.5%) | -$111.40M(+83.5%) | -$452.63M(-3.7%) |
Sep 2024 | - | -$60.71M(-50.0%) | -$470.04M(+0.7%) |
Jun 2024 | - | -$121.39M(-23.7%) | -$466.88M(+14.4%) |
Mar 2024 | - | -$159.12M(+23.5%) | -$408.22M(+37.5%) |
Dec 2023 | -$296.79M(+74.0%) | -$128.81M(+123.8%) | -$296.79M(+27.3%) |
Sep 2023 | - | -$57.55M(-8.3%) | -$233.20M(+8.9%) |
Jun 2023 | - | -$62.74M(+31.6%) | -$214.20M(+12.4%) |
Mar 2023 | - | -$47.69M(-26.9%) | -$190.59M(+11.7%) |
Dec 2022 | -$170.60M(+40.5%) | -$65.22M(+69.2%) | -$170.60M(+9.0%) |
Sep 2022 | - | -$38.55M(-1.5%) | -$156.47M(+6.9%) |
Jun 2022 | - | -$39.13M(+41.2%) | -$146.34M(+7.7%) |
Mar 2022 | - | -$27.70M(-45.8%) | -$135.89M(+11.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$121.39M(+160.3%) | -$51.09M(+79.8%) | -$121.39M(+49.7%) |
Sep 2021 | - | -$28.41M(-0.9%) | -$81.07M(+23.4%) |
Jun 2021 | - | -$28.68M(+117.2%) | -$65.71M(+42.2%) |
Mar 2021 | - | -$13.21M(+22.6%) | -$46.20M(-0.9%) |
Dec 2020 | -$46.63M(-1.1%) | -$10.77M(-17.5%) | -$46.63M(-7.2%) |
Sep 2020 | - | -$13.05M(+42.3%) | -$50.27M(+7.7%) |
Jun 2020 | - | -$9.17M(-32.7%) | -$46.67M(-8.5%) |
Mar 2020 | - | -$13.63M(-5.4%) | -$51.01M(+8.2%) |
Dec 2019 | -$47.15M(+54.7%) | -$14.41M(+52.3%) | -$47.15M(+44.0%) |
Sep 2019 | - | -$9.46M(-30.0%) | -$32.74M(+40.6%) |
Jun 2019 | - | -$13.51M(+38.3%) | -$23.28M(+138.3%) |
Mar 2019 | - | -$9.77M | -$9.77M |
Dec 2018 | -$30.47M | - | - |
FAQ
- What is Vaxcyte annual cash flow from operations?
- What is the all time high annual CFO for Vaxcyte?
- What is Vaxcyte annual CFO year-on-year change?
- What is Vaxcyte quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vaxcyte?
- What is Vaxcyte quarterly CFO year-on-year change?
- What is Vaxcyte TTM cash flow from operations?
- What is the all time high TTM CFO for Vaxcyte?
- What is Vaxcyte TTM CFO year-on-year change?
What is Vaxcyte annual cash flow from operations?
The current annual CFO of PCVX is -$452.63M
What is the all time high annual CFO for Vaxcyte?
Vaxcyte all-time high annual cash flow from operations is -$30.47M
What is Vaxcyte annual CFO year-on-year change?
Over the past year, PCVX annual cash flow from operations has changed by -$155.84M (-52.51%)
What is Vaxcyte quarterly cash flow from operations?
The current quarterly CFO of PCVX is -$166.27M
What is the all time high quarterly CFO for Vaxcyte?
Vaxcyte all-time high quarterly cash flow from operations is -$9.17M
What is Vaxcyte quarterly CFO year-on-year change?
Over the past year, PCVX quarterly cash flow from operations has changed by -$7.15M (-4.49%)
What is Vaxcyte TTM cash flow from operations?
The current TTM CFO of PCVX is -$459.78M
What is the all time high TTM CFO for Vaxcyte?
Vaxcyte all-time high TTM cash flow from operations is -$9.77M
What is Vaxcyte TTM CFO year-on-year change?
Over the past year, PCVX TTM cash flow from operations has changed by -$51.55M (-12.63%)